Denmark· DK-28104119807
Ancozan
A losartan product containing losartankalium, registered in Denmark by Sandoz A/S. The same ATC class is registered in 19 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Losartan is registered in 19 of 19 countries.
Countries holding a registration under ATC C09CA01 (losartan), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 11 of them publish a price we can compare per daily dose
Losartan · ATC C09CA01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of losartan costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.033 in United States to $0.61 in Switzerland — a ×19 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Losartan · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.61
- IT Italy$0.30
- ES Spain$0.17
- FR France$0.10
- US United States$0.033 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- LOSARTANKALIUM
- Manufacturer
- Sandoz A/S
- Country
- Denmark (DK)
- ATC code
- C09CA01
- ATC class
- Losartan
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104119807
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
431 interactions on record for losartan.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Losartan · interactions on record
431 records
- 7 severe
- 139 moderate
- 2 minor
- 198 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
85 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C09CA01
Losartan, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffb34694-0f32-4f03-9310-ff01d423d242 GET /v1/drugs/ffb34694-0f32-4f03-9310-ff01d423d242?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "12,5 mg",
"auth_role": "CMS",
"dk_drugid": "28104119807",
"substance": "LOSARTANKALIUM",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "39679"
}See everything about losartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.